125 related articles for article (PubMed ID: 29350697)
1. Antithrombotic Therapy: Evaluation of the Safety of Performing Core Needle Biopsy of the Breast Without Suspending Medication
.
Cameron P; Lesko J; London MR
Clin J Oncol Nurs; 2018 Feb; 22(1):E18-E22. PubMed ID: 29350697
[TBL] [Abstract][Full Text] [Related]
2. Hematoma formation during breast core needle biopsy in women taking antithrombotic therapy.
Chetlen AL; Kasales C; Mack J; Schetter S; Zhu J
AJR Am J Roentgenol; 2013 Jul; 201(1):215-22. PubMed ID: 23789678
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic Therapy and Hematoma Risk during Image-guided Core-Needle Breast Biopsy.
Loving VA; Johnston BS; Reddy DH; Welk LA; Lawther HA; Klein SC; Cranford CM; Reed RC; Rangan P; Morris MF
Radiology; 2023 Jan; 306(1):79-86. PubMed ID: 35997610
[TBL] [Abstract][Full Text] [Related]
4. Bleeding Events After Image-Guided Breast Biopsies: Comparison of Patients Temporarily Discontinuing Versus Maintaining Antithrombotic Therapy During Biopsy.
Reichman MB; McMahon P; Dwyer M; Chang SJ; Lin H; Katzen J; Thomas C; Drotman MB; Dodelzon K
AJR Am J Roentgenol; 2023 Oct; 221(4):438-449. PubMed ID: 37162038
[No Abstract] [Full Text] [Related]
5. Bleeding Complications After Breast Core-needle Biopsy-An Approach to Managing Patients on Antithrombotic Therapy.
Goudreau S; Grimm LJ; Srinivasan A; Net J; Yang R; Dialani V; Dodelzon K
J Breast Imaging; 2022 Jun; 4(3):241-252. PubMed ID: 38416973
[TBL] [Abstract][Full Text] [Related]
6. Bleeding risk after percutaneous breast needle biopsy in patients on anticoagulation therapy.
McMahon P; Reichman M; Dodelzon K
Clin Imaging; 2021 Feb; 70():114-117. PubMed ID: 33157367
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation and bleeding risk after core needle biopsy.
Somerville P; Seifert PJ; Destounis SV; Murphy PF; Young W
AJR Am J Roentgenol; 2008 Oct; 191(4):1194-7. PubMed ID: 18806164
[TBL] [Abstract][Full Text] [Related]
8. Bleeding Complications following Image-Guided Percutaneous Biopsies in Patients Taking Clopidogrel-A Retrospective Review.
Pieper M; Schmitz J; McBane R; Knudsen J; McMenomy B; Wennberg P; Atwell T
J Vasc Interv Radiol; 2017 Jan; 28(1):88-93. PubMed ID: 27884685
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
[TBL] [Abstract][Full Text] [Related]
10. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract][Full Text] [Related]
11. Safety of omitting routine bleeding tests prior to image-guided musculoskeletal core needle biopsy.
Shif Y; Kung JW; McMahon CJ; Mhuircheartaigh JN; Lin YC; Anderson ME; Wu JS
Skeletal Radiol; 2018 Feb; 47(2):215-221. PubMed ID: 28983679
[TBL] [Abstract][Full Text] [Related]
12. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy.
Wai CJ; Al-Mubarak G; Homer MJ; Goldkamp A; Samenfeld-Specht M; Lee Y; Logvinenko T; Rothschild JG; Graham RA
Ann Surg Oncol; 2013 Mar; 20(3):850-5. PubMed ID: 23104707
[TBL] [Abstract][Full Text] [Related]
13. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
14. Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.
Munch-Petersen HD; Rasmussen BB; Balslev E
APMIS; 2014 Sep; 122(9):750-4. PubMed ID: 24372587
[TBL] [Abstract][Full Text] [Related]
15. Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results.
Melotti MK; Berg WA
AJR Am J Roentgenol; 2000 Jan; 174(1):245-9. PubMed ID: 10628487
[TBL] [Abstract][Full Text] [Related]
16. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Peña A; Shah SS; Fazzio RT; Hoskin TL; Brahmbhatt RD; Hieken TJ; Jakub JW; Boughey JC; Visscher DW; Degnim AC
Breast Cancer Res Treat; 2017 Jul; 164(2):295-304. PubMed ID: 28474262
[TBL] [Abstract][Full Text] [Related]
17. Complex sclerosing lesions and radial sclerosing lesions on core needle biopsy: Low risk of carcinoma on excision in cases with clinical and imaging concordance.
Nakhlis F; Lester S; Denison C; Wong SM; Mongiu A; Golshan M
Breast J; 2018 Mar; 24(2):133-138. PubMed ID: 28685897
[TBL] [Abstract][Full Text] [Related]
18. Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised.
Jaffer S; Bleiweiss IJ; Nagi C
Breast J; 2013; 19(2):130-3. PubMed ID: 23336823
[TBL] [Abstract][Full Text] [Related]
19. Management of percutaneous core biopsy tract bleeding.
Gadgil PV; Klimberg VS
Ann Surg Oncol; 2013 Oct; 20(10):3348. PubMed ID: 23975285
[No Abstract] [Full Text] [Related]
20. Why are patients noncompliant with follow-up recommendations after MRI-guided core needle biopsy of suspicious breast lesions?
Thompson MO; Lipson J; Daniel B; Harrigal C; Mullarkey P; Pal S; Thompson AC; Ikeda D
AJR Am J Roentgenol; 2013 Dec; 201(6):1391-400. PubMed ID: 24261382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
